⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DARE News
Dare Bioscience, Inc. Common Stock
Daré Bioscience Sponsors HERmedicine Educational Program for Clinicians on Managing Menopause After Breast Cancer
globenewswire.com
DARE
Daré Bioscience Launches “CEO Corner” Video Series to Highlight the Company’s Pipeline of Women’s Health Innovations, Corporate Strategy and Opportunities
globenewswire.com
DARE
Daré Bioscience to Present Phase 1 Sildenafil Cream Data at Sexual Medicine Society of North America (SMSNA) Annual Fall Scientific Meeting
globenewswire.com
DARE
Mexico Reversible Contraceptive Devices (IUDs, Hormonal Implants, Diaphragms) Outlook to 2033: Market Revenue, Volume, Pricing and Competitive Analysis
globenewswire.com
ORGO
DARE
Form 8-K
sec.gov
DARE
Form 8-K
sec.gov
DARE
Dare Bioscience Announces New U.S. Patent Strengthening DARE-HPV Program as a Potential First FDA-Approved Pharmacologic Treatment for HPV Infection
globenewswire.com
DARE
Daré Bioscience Announces Peer-Reviewed Publication of Phase 1 Sildenafil Cream Study in Men Demonstrating Substantially Lower Systemic Exposure Versus Oral Sildenafil
globenewswire.com
DARE
Form 8-K
sec.gov
DARE
Daré Bioscience Presentation for H.C. Wainwright 28th Annual Global Investment Conference Now Available On-Demand
globenewswire.com
DARE